Abstract A hallmark of gliomas is the growth and migration of cells over long distances within the brain and proliferation within selected niches, indicating that the migrating cells navigate between complex substrates. We demonstrate in the present study a differential preference for migration that de-pends on Rho-associated coil kinase (ROCK) signaling, using the alternating Bonhoeffer stripe assay. Membrane fractions from nonmyelinated and myelinated brain areas from female rats, purified myelin also from female rats, and commercial extracellular matrix were used as substrates, with each sub-strate being tested against the others. The human tumor cell lines exhibited a clear preference for extracellular matrix over all other substrates a...
The complexity of the microenvironment effects on cell response, show accumulating evidence that gli...
Glioblastoma multiforme (GBM), the most prevalent primary brain cancer, is characterized by diffuse ...
© 2020, Springer Nature Switzerland AG. Tumor cell invasiveness is a critical challenge in the clini...
Glioblastoma multiforme (GBM) is the most common and deadliest brain cancer in adults. Despite consi...
A key reason for malignant glioma recurrence after radical tumor resection is the failure to contro...
Background: A hallmark of glioblastoma is represented by their ability to widely disperse throughout...
We have investigated the role of the Rho/ROCK signaling pathway in the interaction of metastatic mel...
Background: A hallmark of glioblastoma is represented by their ability to widely disperse throughout...
Glioblastoma remains elusive to treat due to the diffuse infiltration of single tumor cells into the...
Bone marrow-derived stromal cells (BMSCs), also known as mesenchymal stem cells, are the focus of in...
Background Glioblastoma (GBM) is a highly aggressive incurable brain tumor. The main cause of mortal...
Introduction: Bone marrow-derived stromal cells (BMSCs), also known as mesenchymal stem cells, are t...
Understanding the molecular processes characterizing Ewing sarcoma (EWS) cell migration is crucial t...
Deni S. GalileoGlioblastoma multiforme (GBM), the most lethal of brain tumors, spreads rapidly in th...
Tumor stem cells and malignant multicellular networks have been separately implicated in the therape...
The complexity of the microenvironment effects on cell response, show accumulating evidence that gli...
Glioblastoma multiforme (GBM), the most prevalent primary brain cancer, is characterized by diffuse ...
© 2020, Springer Nature Switzerland AG. Tumor cell invasiveness is a critical challenge in the clini...
Glioblastoma multiforme (GBM) is the most common and deadliest brain cancer in adults. Despite consi...
A key reason for malignant glioma recurrence after radical tumor resection is the failure to contro...
Background: A hallmark of glioblastoma is represented by their ability to widely disperse throughout...
We have investigated the role of the Rho/ROCK signaling pathway in the interaction of metastatic mel...
Background: A hallmark of glioblastoma is represented by their ability to widely disperse throughout...
Glioblastoma remains elusive to treat due to the diffuse infiltration of single tumor cells into the...
Bone marrow-derived stromal cells (BMSCs), also known as mesenchymal stem cells, are the focus of in...
Background Glioblastoma (GBM) is a highly aggressive incurable brain tumor. The main cause of mortal...
Introduction: Bone marrow-derived stromal cells (BMSCs), also known as mesenchymal stem cells, are t...
Understanding the molecular processes characterizing Ewing sarcoma (EWS) cell migration is crucial t...
Deni S. GalileoGlioblastoma multiforme (GBM), the most lethal of brain tumors, spreads rapidly in th...
Tumor stem cells and malignant multicellular networks have been separately implicated in the therape...
The complexity of the microenvironment effects on cell response, show accumulating evidence that gli...
Glioblastoma multiforme (GBM), the most prevalent primary brain cancer, is characterized by diffuse ...
© 2020, Springer Nature Switzerland AG. Tumor cell invasiveness is a critical challenge in the clini...